Results 231 to 240 of about 683,284 (269)

Correction: Impact of patients' age and comorbidities on prostate cancer overdiagnosis in clinical practice. [PDF]

PLoS One
Beltrán A, Parker L, Moral Peláez I, Caballero-Romeu JP, Chilet-Rosell E, Hernández-Aguado I, Alonso-Coello P, Ronda E, Gómez-Pérez L, Lumbreras B.   +9 more
europepmc   +1 more source

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF‐κB and TGF‐β Signaling Pathways

Advanced Science, EarlyView.
This research provides the first comprehensive evidence that PS‐MPs exacerbate ccRCC progression by activating the NF‐κB and TGF‐β pathways. These findings establish PS‐MPs as an environmental risk factor for ccRCC progression and identify the NF‐κB and TGF‐β signaling as potential therapeutic targets to mitigate the adverse effects of ‐PS‐MPs exposure.
Shiqi Ye, Jianfeng Xiang, Siqi Zhou, Qintao Ge, Aihetaimujiang Anwaier, Kun Chang, Gang Wei, Jiahe Lu, Xi Tian, Shuxuan Zhu, Yuchen Jiang, Wei Zhang, Tingting Cai, Moran Xu, Dingwei Ye, Danfeng Xu, Tao Wang, Hailiang Zhang, Wenhao Xu   +18 more
wiley   +1 more source

Erratum to "Consensus-built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative". [PDF]

Cancer
europepmc   +1 more source

Identification of progression markers for prostate cancer. [PDF]

Cell Cycle
Song J, Zhou Y, Hedman H, Rantapero T, Landström M.   +4 more
europepmc   +1 more source

Microenvironment‐Guided Evolution of ssDNA‐SWCNT Probes for Selective Recognition of Aggressive Prostate Cancer Phenotypes

Advanced Science, EarlyView.
Random ssDNA–SWCNT(single strand DNA‐single walled carbon nanotube) library is functionally screened and evolved using high‐throughput 3D prostate tumor spheroids via iterative positive and negative selection, enabling the identification of NIR‐II fluorescent ssDNA‐SWCNT nanoprobe specific for prostate cancer.
Dakyeon Lee, Seok‐Hyeon Lee, Yunseo Jung, Jeongho Lee, Min‐Seo Choi, SaeOck Oh, Sungjee Kim, Byoung Soo Kim, Sanghwa Jeong   +8 more
wiley   +1 more source

Methylation-based signature to distinguish indolent and aggressive prostate cancer. [PDF]

Biol Open
Liao M, Webster J, Ly A, Rozycki E, Maher CA.   +4 more
europepmc   +1 more source

Radiomics Reproducibility in Prostate Cancer Diagnosis Based on PROSTATEx. [PDF]

Int Neurourol J
Jung S, Kim JS.
europepmc   +1 more source

The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies. [PDF]

Front Oncol
Wang B, Zhang Y, Zhang W.
europepmc   +1 more source

Identification of prognostic biomarkers and development of a prediction model for prostate cancer. [PDF]

Front Immunol
Chen D, Chen W, Ye R, Li L, Miao F, Kong X, Ning W, Jia J, Chen Q, Wang P, Yin B.   +10 more
europepmc   +1 more source